Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Annelies van Vuren"'
Autor:
Annelies van Vuren, Bert van der Zwaag, Rick Huisjes, Nathalie Lak, Marc Bierings, Egbert Gerritsen, Eduard van Beers, Marije Bartels, Richard van Wijk
Publikováno v:
HemaSphere, Vol 3, Iss 4 (2019)
Abstract. Hereditary spherocytosis (HS) is a phenotypically and genetically heterogeneous disease. With the increased use of Next Generation Sequencing (NGS) techniques in the diagnosis of red blood cell disorders, the list of unique pathogenic mutat
Externí odkaz:
https://doaj.org/article/d5f51408f9bc40ef91dbea404efac77a
Autor:
Simon Grootendorst, Jonathan de Wilde, Birgit van Dooijeweert, Annelies van Vuren, Wouter van Solinge, Roger Schutgens, Richard van Wijk, Marije Bartels
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4, p 2204 (2021)
Rare hereditary anemias (RHA) represent a group of disorders characterized by either impaired production of erythrocytes or decreased survival (i.e., hemolysis). In RHA, the regulation of iron metabolism and erythropoiesis is often disturbed, leading
Externí odkaz:
https://doaj.org/article/a668a767227c4e03a1f74ddefe4c6b0a
Autor:
Annelies van Vuren, Jean Louis Kerkhoffs, Saskia Schols, Anita Rijneveld, Erfan Nur, Dore Peereboom, Yves Gandon, Paco Welsing, Richard van Wijk, Roger Schutgens, Wouter van Solinge, Joannes Marx, Tim Leiner, Bart Biemond, Eduard van Beers
Publikováno v:
American Journal of Hematology, 97, 924-932
American Journal of Hematology, 97(7), 924-932. Wiley-Liss Inc.
van Vuren, A, Kerkhoffs, J L, Schols, S, Rijneveld, A, Nur, E, Peereboom, D, Gandon, Y, Welsing, P, van Wijk, R, Schutgens, R, van Solinge, W, Marx, J, Leiner, T, Biemond, B & van Beers, E 2022, ' Proton pump inhibition for secondary hemochromatosis in hereditary anemia : a phase III placebo-controlled randomized cross-over clinical trial ', American Journal of Hematology, vol. 97, no. 7, pp. 924-932 . https://doi.org/10.1002/ajh.26581
American journal of hematology, 97(7), 924-932. Wiley-Liss Inc.
American Journal of Hematology, 97, 7, pp. 924-932
American Journal of Hematology, 97(7), 924-932. Wiley-Liss Inc.
van Vuren, A, Kerkhoffs, J L, Schols, S, Rijneveld, A, Nur, E, Peereboom, D, Gandon, Y, Welsing, P, van Wijk, R, Schutgens, R, van Solinge, W, Marx, J, Leiner, T, Biemond, B & van Beers, E 2022, ' Proton pump inhibition for secondary hemochromatosis in hereditary anemia : a phase III placebo-controlled randomized cross-over clinical trial ', American Journal of Hematology, vol. 97, no. 7, pp. 924-932 . https://doi.org/10.1002/ajh.26581
American journal of hematology, 97(7), 924-932. Wiley-Liss Inc.
American Journal of Hematology, 97, 7, pp. 924-932
Contains fulltext : 251634.pdf (Publisher’s version ) (Open Access) Iron overload is a severe general complication of hereditary anemias. Treatment with iron chelators is hampered by important side-effects, high costs, and the lack of availability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82313408bcd14e01ba7f8f34be19ee35
https://doi.org/10.1002/ajh.26581
https://doi.org/10.1002/ajh.26581
Publikováno v:
Pediatric bloodcancer. 61(12)
Antibody therapy has become standard of care for adult B cell lymphoma patients. It is a potentially less toxic and more targeted approach for lymphoma therapy and should therefore be applied to treat pediatric B cell lymphoma patients as well. In pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::992209258835240597671cc22ba0d442
https://pubmed.ncbi.nlm.nih.gov/25154500
https://pubmed.ncbi.nlm.nih.gov/25154500